focus -WSS

focus

author：Wikipedia 2025-09-28 19:25:31 - browse：2

Alex Hogan/STAT

The J.P. Morgan Healthcare Conference is upon us, bringing its frenetic meetings, crowded hallways, and hotel rooms so expensive that even the pharmaceutical industry complains about what a free market does to the prices of scarce goods.

This year’s iteration, starting Monday in San Francisco, finds the biotech industry, in particular, in a curious spot. After a volatile 2023 that saw biotech stocks hit five-year lows in the fall, the sector had a bull run in the final weeks of the year, spurred by some high-dollar merger agreements and a prevailing sense that the macroeconomic winds were finally shifting in biotech’s direction.

Meanwhile, companies selling digital health services like telemedicine, health plans for virtual care, and AI tools for payers face a crucial year as they scramble to make good on profitability projections. Those companies, along with the country’s most powerful health systems, are seriously exploring AI, even ChatGPT, to help them meet financial milestones.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： How clinical AI models' predictive power can degrade over time

WSS

Wellcome Trust names Røttingen as its new CEO

Wellcome Trust names Røttingen as its new CEO

For BCIs, commercial hurdles may be bigger than scientific ones

How clinical AI models' predictive power can degrade over time

Researchers CRISPR chickens in bid to protect them from bird flu

Humana CEO Bruce Broussard to step down in 2024

hotspot

focus

hotspot

Medicare details structure of new drug price negotiation program

A fraught question for the kids of Alzheimer’s: Is it coming for us?

Wildfire smoke exposes gaps in outdoor worker protections

Gilgo Beach: Police identify another victim in serial killing investigation

Peter Hotez and the public health issue of online harassment

Peter Marks talks Operation Warp Speed for Rare Diseases

Virginia high school admissions case could be legal follow

STAT Readout: Today's biotech news includes Sana and Amylyx

23andMe had bad news about my health. I wish a person had delivered it

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

leisure time

A cyberattack has disrupted hospitals and health care in several states

Female surgeons have lower rates of long

How doctors and nurses shape Google's AI

Biden calls for immediate release of Niger's president amid apparent coup

TytoCare raises $49 million to build out AI

Humana CEO Bruce Broussard to step down in 2024

knowledge

hotspot

focus

leisure time